Director, National Institute for Stroke and Applied Neurosciences, and Professor of Epidemiology & Neurology
Phone: 09 921 9166
AUT North shore campus
90 Akoranga Drive
Northcote, Auckland 0627
National Institute for Stroke and Applied Neurosciences (mail code A-12)
Private Bag 92006
Valery is the Director of AUT’s National Institute for Stroke and Applied Neuroscience (NISAN). It is the only national research institute solely dedicated to studying the epidemiology and prevention of neurological disorders in New Zealand. These disorders affect one in five New Zealanders.
After graduating in medicine from the State Medical School of Novosibirsk, Russia, his subsequent advanced training in neurology and clinical epidemiology research has taken him from Moscow to the Mayo Clinic in America and also Erasmus University in the Netherlands. Professor Feigin has been at AUT since 2008.
Valery is the Editor-in-Chief of the international journal Neuroepidemiology and an Editorial Board member of 15 other international medical journals. He is a member of the Core Analytic Team for the Global Burden of Disease (GBD) Study at the Institute for Health Metrics Evaluation, University of Washington, leading the Neurology Section of the GBD Study that includes six expert panels, including the Stroke Experts Panel, which contributes data to the WHO regular reports that are distributed all over the world. He is also a member of the Advisory Working Group on Stroke for the WHO ICD-11 version. He is currently on the World Stroke Organization Board of Directors, a member of the Science Leadership Team of the NSC Ageing Well Programme, and Principal Investigator and member of the Management Team of the Brain Research NZ CoRE.
With over 910,000 downloads of his papers (ScienceDirect, December 2018) that have been cited by over 69,600 times (according to Google Scholar) and >42,000 times (by Scopus), Valery’s papers are currently ranked by ScienceDirect in the top 1% by citations.
Valery is the recipient of a number of prestigious national and international awards and distinctions, including the Fogarty International Centre Research Grant Award (National Institute of Neurological Disorders & Stroke of the USA, Mayo Clinic), Bruce Shoenburg International Award and Lecture in Neuroepidemiology (American Academy of Neurology), Gedeon Richter Award for Studies on Cavinton in Acute Stroke, and the World Stroke Organization President’s Award for his outstanding contribution to clinical stroke research.
Most recently, in 2015, Valery was awarded the Royal Society of New Zealand’s MacDiarmid Medal, for outstanding research in stroke epidemiology and prevention worldwide, and the development of ground-breaking technology in primary stroke prevention.